Type 2 Diabetes Treatment: Global Market Outlook

Jan 2023| HLC287A| BCC Publishing

Report Highlights

The goal is to provide an up-to-date analysis of the global type 2 diabetes treatment market and future opportunities in the market. It presents a thorough and up-to-date global assessment of the market and business of the type 2 diabetes treatment. This will help industry participants, suppliers, government bodies, associations, and customers make the informed decisions needed to compete and succeed in the marketplace. The scope of the study includes the various types of medicines involved in type 2 diabetes treatment and management. Blood glucose monitoring, diagnostic systems and devices, and insulin-delivery devices used in the treatment of type 2 diabetes, however, have been excluded from this study.

Report Includes

  • A comprehensive overview of the global market for the treatment of type 2 diabetes
  • Analyses of the global and regional market trends, with historic revenue data from 2019 to 2021, estimates for 2022 and 2023, and projections of compound annual growth rates (CAGRs) through 2027
  • Understanding of the current and future market potential for this innovation driven market, and areas of focus to forecast the market into various segments and sub-segments
  • Discussion of the industry growth driving factors and challenges that will shape the market for type 2 diabetes treatment as the basis for projecting demand in the next few years (2022-2027)
  • Estimation of the actual market size and revenue forecast for global type 2 diabetes treatment market, and corresponding market share analysis by therapy type, route of administration, end user, and region
  • Holistic review of the COVID-19 pandemic implications on the global market for treatment of type 2 diabetes
  • Review of the patent grants and patent applications on type 2 diabetes treatment solutions and related technologies
  • Identification of the major stakeholders and analysis of the competitive landscape based on recent developments and segmental revenues

Report Scope

In this report, the market has been segmented based on route of administration, therapy type and region. The report provides an overview of the global type 2 diabetes treatment market and analyses market trends. Using 2021 as the base year, it provides estimated market data for the forecast period of 2022 to 2027. Revenue forecasts for this period are segmented based on route of administration, therapy type and geography. Market values have been estimated based on the total revenue of type 2 diabetes therapies providers.

The report covers the market for type 2 diabetes treatment with regard to the therapy type across different regions. It also highlights major trends and challenges that affect the market and the vendor landscape. It estimates the global market for type 2 diabetes treatment in 2021, and then provides projections for the expected market size through 2027.

The scope of the study includes the various types of medicines involved in type 2 diabetes treatment and management. Blood glucose monitoring, diagnostic systems and devices, and insulin-delivery devices used in the treatment of type 2 diabetes, however, have been excluded from this study.

Frequently Asked Questions (FAQs)

The global type 2 diabetes treatment market is projected to grow from $52.6 billion in 2021 to $77.2 billion in 2027, at a compound annual growth rate (CAGR) of 6.6% during the forecast period.
Rising prevalence of diabetes, next generation of type 2 diabetes treatment, high unmet need and premium pricing for innovative drugs are the key factors driving the growth of the type 2 diabetes treatment market.
In the report, the type 2 diabetes treatment market has been segmented based on route of administration, therapy type, and region.
Oral medications will dominate the market by the end of 2027.
Key companies in the market include Novo Nordisk A/S, Eli Lilly and Co., Boehringer Ingelheim, Merck & Co. Inc., and AstraZeneca PLC.

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.

Report Synopsis

Report Metrics Details
Base year considered 2021
Forecast period considered 2022 to 2027
Base year market size $52.6 billion
Market size forecast $77.2 billion
Growth rate CAGR of 6.6% for the forecast period of 2022-2027
Units considered $ Millions
Segments covered route of administration, therapy type, and region
Regions covered North America, Europe, Asia-Pacific, and Rest of the World (ROW)
Key Market Drivers
  • Rising Prevalence of Diabetes
  • Next Generation of Type 2 Diabetes Treatment
  • High Unmet Need
  • Premium Pricing
  • Collaborations and Licensing Agreements
  • Loss of Exclusivity, Genericization and Pricing Pressure
  • Evolving Regulatory Scenario
Companies studied
  • ASTRAZENECA
  • BIOCON LTD.
  • BOEHRINGER INGELHEIM INTERNATIONAL GMBH
  • ELI LILLY AND CO.
  • JANSSEN GLOBAL SERVICES LLC.
  • MERCK & CO. INC.
  • NOVARTIS AG
  • NOVO NORDISK A/S
  • SANOFI

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Type 2 Diabetes Treatment: Global Market Outlook66Free
Type 2 Diabetes Treatment: Global Market Outlook

Single User License: $3500

Become a Member

Already a member? Login to access this report free.

Have a Question? Ask Us.

Why BCC Research.?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
Custom Research

Need a custom data table, graph or complete report? Tell us more.

RELATED REPORTS